Impact Of Low-Frequency HIV-1 Drug Resistance Mutations On Antiretroviral Therapy Outcomes.

Rachel BurdorfShuntai ZhouClaire AmonNathan LongCollin S HillLily AdamsGerald TeghaMaganizo B ChagomeranaAllan JumbeMadalitso MaliwichiShaphil WallieYijia LiRonald SwanstromMina C Hosseinipour

Published in: The Journal of infectious diseases (2024)

Using accurate NGS for DRM detection may benefit an additional 10% of the patients by identifying low-frequency K103N mutations.

Keyphrases

antiretroviral therapy
hiv infected
human immunodeficiency virus
hiv positive
end stage renal disease
hiv aids
ejection fraction
hiv infected patients
newly diagnosed
peritoneal dialysis
hepatitis c virus
prognostic factors
type diabetes
metabolic syndrome
south africa
adipose tissue
weight loss